Search

Your search keyword '"Shah, Mithun V."' showing total 474 results

Search Constraints

Start Over You searched for: Author "Shah, Mithun V." Remove constraint Author: "Shah, Mithun V."
474 results on '"Shah, Mithun V."'

Search Results

1. Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms

2. Clinical features and outcomes in primary nervous system histiocytic neoplasms

4. Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

6. Neurological Manifestations of Histiocytic Disorders

8. Long-term outcomes among adults with Langerhans cell histiocytosis

11. Clinicopathologic correlates and prognostic impact of lymphoid aggregates in patients with myelodysplastic syndromes.

12. Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

13. IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation

16. IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation

17. Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS)

18. Factors Predicting Survival in Patients with TP53-Mutated Myeloid Neoplasms Following Allogeneic Stem Cell Transplant

19. Coronary Artery Calcium As a Predictor of Non-Relapse Mortality and Overall Survival in Patients Undergoing Post-Transplant Cyclophosphamide As Gvhd Prophylaxis

20. Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms

21. Impact of Wilms Tumor (WT1) Mutation on Relapse and Overall Survival in Acute Myeloid Leukemia Patients Following Allogenic Stem Cell Transplantation

23. Pilot Prospective Study of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Vexas Syndrome

30. BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

31. A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy

32. Reply

33. Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a ‘graft versus host’-like syndrome and poor outcomes

34. Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation

36. Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

39. The clinical and molecular spectrum ofETV6mutated myeloid neoplasms

40. Dedifferentiation of B-lymphoblastic leukemia/lymphoma with t(9;22) BCR::ABL1 to an undifferentiated neoplasm with strong keratin expression in a patient receiving blinatumomab

41. Outpatient Practice Pattern for Recently Approved CAR-T in Patients with Lymphoma and Multiple Myeloma

44. Efficacy of Donor Lymphocyte Infusions in Achieving Disease Control Among Myeloid Malignancy Patients Treated with an Allogeneic Hematopoietic Stem Cell Transplantation

45. Hematopoietic Stem Cell Transplant Outcome in STAG2-Mutated Myeloid Neoplasms

46. Surrogates of Endothelial Injury Predict Non-Relapse Mortality Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis

47. Ophthalmologic Involvement in Adults with Histiocytic Disorders

48. Seronegative Rheumatoid Arthritis and Innate Immune Activation is Frequent in Myeloid Neoplasms with Isocitrate Dehydrogenase 1/2 Mutations

49. Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm

50. Sirolimus as frontline therapy for PTEN-mutated histiocytic sarcoma

Catalog

Books, media, physical & digital resources